Investor Presentaiton slide image

Investor Presentaiton

Investor Presentation First nine months of 2018 Slide 21 Appendix 1. First nine months of 2018 highlights and NN at a glance 22 2. Insulin 3. GLP-1 diabetes 45 69 4. Obesity 89 5. Biopharmaceuticals & Other serious chronic diseases 98 6. Financials 110 7. Sustainable business 122 NN: Novo Nordisk changing diabetes® novo nordisk
View entire presentation